Business
Trinity Capital Inc. Provides $35 Million in Growth Capital to Neuros Medical, Inc. to Scale Pain Management Therapy Adoption
PHOENIX, March 10, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading international alternative asset manager, today
About this update from Trinity Capital Inc.
[{"type":"text","content":"PHOENIX, March 10, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the \"Company\"), a leading international alternative asset manager, today announced the commitment of $35 million in growth capital to Neuros Medical, Inc., a MedTech company focused on alleviating chronic post-amputation pain and restoring quality of life through neuromodulation technologies.\n \n \n \n \n \n \n \nNeuros Medical's FDA-approved Altius Direct Electrical Nerve Stimulation System targets pain at its source by interrupting peripheral nerve signals responsible for phantom limb and residual limb pain. The system enables patients to activate therapy when needed, delivering targeted pain relief without relying on continuous medication. With treatment options historically limited to opioid-based therapies, Altius offers a differentiated alternative for post-amputation pain.\"Neuros Medical has reached an important inflection point as their technology moves into real-world adoption. We are proud to continue to support their team as they expand access to a differentiated therapy that addresses a significant need within the life sciences ecosystem,\" said Rob Lake, Senior Managing Director, Life Sciences at Trinity Capital.This new capital will help Neuros Medical scale the commercialization of the Altius system and expand into new markets.\"We appreciate the continued partnership from Trinity,\" said David Veino, President & CEO of Neuros Medical. \"The Trinity team has been an important partner prior to us achieving FDA approval and will remain an important partner as we expand. This expansion of our debt facility provides important financial flexibility as Neuros enters the next phase of its mission to Relieve Pain and Restore Life for this underserved patient population.\"About Trinity Capital Inc.Trinity Capital Inc. (Nasdaq: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences. As a long-term, trusted partner for innovative companies seeking tailored debt solutions, Trinity Capital has deployed more than $5.5 billion across o...